Nanoflex Robotics, a Zurich, Switzerland-based magnetically controlled medical soft robotics company, raised initial $12M in funding.
The round was led by Ascend Capital Partners with participation from Kinled Holding Ltd and Mountain Labs AG. Jerry Hong, CEO of Ascend Capital Partners, will join the board of directors.
Led by CEO Matt Curran, Nanoflex Robotics is a MedTech startup that has developed a proprietary robotic platform to navigate magnetic devices in complex vascular anatomy using precise electromagnetic fields. Its portfolio of products is intended to diagnose and treat vascular disease, including acute ischemic stroke, in a timely and safe manner. Nanoflex Robotics’ first product will be a compact and mobile electromagnetic field generator that can easily be moved between hospital interventional suites, requiring no additional infrastructure beyond a high voltage electrical point and access to a water-based cooling system. The system allows direct tip control of magnetically adapted interventional devices, in contrast to conventional procedures where torque must often be transferred more than a meter down the length of devices to control tip direction.
The company intends to use the funds to bring its first-generation system to market and to accelerate development of new neuro-interventional products. The funding will drive first-in-human and regulatory clearance of its robotic platform to precisely steer wires and catheters through vasculature using electromagnetic fields. A first-in-human trial and FDA submission is planned for Q3 2023.
FinSMEs
10/02/2023